MustGrow Biologics Corp. (FRA:0C0)

Market Cap	16.13M -39.7%
Revenue (ttm)	5.86M +1,237.8%
Net Income	-3.43M
EPS	-0.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.2020
Previous Close	0.2140
Day's Range	0.2020 - 0.2020
52-Week Range	0.1630 - 0.5820
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 25, 2026

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2014
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 0C0

Financial Performance

In 2025, MustGrow Biologics's revenue was 8.29 million, an increase of 1981.95% compared to the previous year's 398,018. Losses were -7.26 million, 48.5% more than in 2024.

Financial numbers in CAD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error